- Patent Title: Compound as WNT signaling inhibitor, composition, and use thereof
-
Application No.: US15359900Application Date: 2016-11-23
-
Publication No.: US10087181B2Publication Date: 2018-10-02
- Inventor: Songzhu An
- Applicant: CUREGENIX, INC.
- Applicant Address: CN Guangdong
- Assignee: CUREGENIX, INC.
- Current Assignee: CUREGENIX, INC.
- Current Assignee Address: CN Guangdong
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Robert W. Winn
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/14 ; C07D217/22 ; C07D401/12
Abstract:
The present invention related to a compound having the structure of Formula I as inhibitor of WNT signal transduction pathways, as well as a composition comprising the compound. Further, the present invention relates to the use of the compound and the method of inhibiting the WNT signal transduction pathways.
Public/Granted literature
- US20170073344A1 Compound as WNT Signaling Inhibitor, Composition, and Use Thereof Public/Granted day:2017-03-16
Information query
